Related Articles
A novel prognostic prediction model for recurrence in patients with stage II colon cancer after curative resection Corrigendum in /10.3892/mco.2019.1879
Significance of postoperative adjuvant immunochemotherapy after curative resection of colorectal cancers: Identification of responders incorporating the age factor
High postoperative carcinoembryonic antigen as an indicator of high‑risk stage II colon cancer
Predictive factors associated with relapse of stage II/III colon cancer treated with peroral anti‑cancer agents in the adjuvant setting
The expression of vascular endothelial growth factor determines the efficacy of post-operative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer